Hikari Power LTD Biogen Inc. Transaction History

Hikari Power LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $219,861 - $291,167	-850 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $2.92 Million - $4.04 Million	-13,280 Reduced 93.98%	850 $252,000
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $28,507 - $31,423	-130 Reduced 0.91%	14,130 $3.31 Million
Q3 2018 Oct 31, 2018	SELL	$293.51 - $383.83 $1.67 Million - $2.18 Million	-5,680 Reduced 28.49%	14,260 $5.04 Million
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $715,905 - $853,209	-2,780 Reduced 12.24%	19,940 $5.79 Million

Q2 2017 Aug 09, 2017	BUY	N/A	22,720	22,720 $6.17 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

Stay updated on Hikari Power LTD with notifications on news.